Roche and Vernalis Group

Published: 18-Apr-2002
Sustainability


Roche and Vernalis Group have signed a new agreement to collaborate on the r&d of novel drugs for the treatment of diabetes. Dr Jonathan Knowles, president of Global Pharma Research at Roche, said: 'Metabolic diseases represent a high unmet medical need. Both companies will focus on the discovery of novel molecular entities, acting through novel mechanisms of action, to target the improvement of the dysfunctional metabolic status in diabetic patients.'

See more

You may also like

You need to be a subscriber to read this article.
Click here to find out more.
Sustainability

Integrating responsible AI into ESG strategies

Read more
Today, artificial intelligence (AI) is changing the way businesses operate, but there’s no denying that it presents both opportunities and risks

Trending Articles

  1. You need to be a subscriber to read this article.
    Click here to find out more.
    Integrating responsible AI into ESG strategies Today, artificial intelligence (AI) is changing the way businesses operate, but there’s no denying that it presents both opportunities and risks
  2. An interdisciplinary team taking concrete steps Sustainability is about much more than just reducing carbon emissions. It also entails a sense of responsibility for social and environmental matters, something that has always been important to the fluidics experts at Bürkert. However, the family-run business believes that previous approaches in this area have not gone far enough in tackling global climate change. Instead, it is taking a more holistic view that is using the regenerative economy concept as an umbrella covering all the actions it is undertaking. This is the company’s North Star – the long-term goal with which it is aligning its actions.
  3. Symeres secures first SBTi approval for science-based emissions reduction targets The company has earned its first Science Based Targets initiative (SBTi) approval, validating its greenhouse gas reduction targets and reinforcing its commitment to supporting pharmaceutical clients’ net-zero and sustainability goals
  4. You need to be a subscriber to read this article.
    Click here to find out more.
    Requalification as a strategic opportunity for sustainable pharmaceutical packaging Requalification is often viewed as a critical — albeit inconvenient — disruption in pharmaceutical operations, which is essential to ensure product quality, consistency and safety
  5. Corplex demonstrates environmental leadership with Carbon Neutral Certification Corplex has been certified carbon neutral across its global operations. The achievement covers the calendar year of 2024 and has been independently verified by VERRA and supported by South Pole

Upcoming event

From powder to granules: a deep dive into wet granulation methods

14 January 2026 | Virtual See all

You may also like

You need to be a subscriber to read this article.
Click here to find out more.
Sustainability

Integrating responsible AI into ESG strategies

Today, artificial intelligence (AI) is changing the way businesses operate, but there’s no denying that it presents both opportunities and risks
Packaging

Corplex demonstrates environmental leadership with Carbon Neutral Certification

Corplex has been certified carbon neutral across its global operations. The achievement covers the calendar year of 2024 and has been independently verified by VERRA and supported by South Pole
Sustainability

Symeres secures first SBTi approval for science-based emissions reduction targets

The company has earned its first Science Based Targets initiative (SBTi) approval, validating its greenhouse gas reduction targets and reinforcing its commitment to supporting pharmaceutical clients’ net-zero and sustainability goals
Sustainability

An interdisciplinary team taking concrete steps

Sustainability is about much more than just reducing carbon emissions. It also entails a sense of responsibility for social and environmental matters, something that has always been important to the fluidics experts at Bürkert. However, the family-run business believes that previous approaches in this area have not gone far enough in tackling global climate change. Instead, it is taking a more holistic view that is using the regenerative economy concept as an umbrella covering all the actions it is undertaking. This is the company’s North Star – the long-term goal with which it is aligning its actions.
You need to be a subscriber to read this article.
Click here to find out more.
Packaging

Requalification as a strategic opportunity for sustainable pharmaceutical packaging

Requalification is often viewed as a critical — albeit inconvenient — disruption in pharmaceutical operations, which is essential to ensure product quality, consistency and safety
Manufacturing

Titan Enterprises highly commended for Manufacturer of the Year at industry awards

Recognition reflects the company’s investment in innovation and precision flow measurement
Manufacturing

IWK introduces machine to produce 100% cardboard blister packaging

CABLIblue 870 features innovative “card-to-card” technology for recyclable, fiber-based blisters
Subscribe now